11 – 20 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
SERPINH1 variants and thrombotic risk among middle-aged and older adults : a population-based cohort study
Manderstedt, Eric LU ; Lind-Halldén, Christina ; Halldén, Christer LU ; Elf, Johan LU ; Svensson, Peter J. LU ; Engström, Gunnar LU ; Melander, Olle LU
; Baras, Aris
; Lotta, Luca A.
and Zöller, Bengt
LU
(2024)
In Journal of Thrombosis and Haemostasis
22(3).
p.869-873
- Contribution to journal › Letter
- 2023
-
Mark
"Hereditary angioedema is associated with an increased risk of venous thromboembolism" : reply
Grover, Steven P. ; Björkman, Linda Sundler LU
; Egesten, Arne
LU
; Moll, Stephan
and Mackman, Nigel
(2023)
In Journal of thrombosis and haemostasis : JTH
21(1).
p.180-182
- Contribution to journal › Letter
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
- Contribution to journal › Article
-
Mark
“C1-inhibitor levels and Venous Thromboembolism : Results from a Mendelian Randomization Study”: comment from Grover et al
Grover, Steven P. ; Sundler Björkman, Linda LU
; Brækkan, Sigrid K.
; Zöller, Bengt
LU
; Hansen, John Bjarne
and Mackman, Nigel
(2023)
In Journal of Thrombosis and Haemostasis
21(10).
p.2985-2987
- Contribution to journal › Letter
-
Mark
Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders
- Contribution to journal › Article
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
- Contribution to journal › Scientific review
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
- Contribution to journal › Article
- 2022
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
- Contribution to journal › Article
-
Mark
A hydrophobic patch (PLVIVG; 1481–1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
- Contribution to journal › Article
-
Mark
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study
- Contribution to journal › Article